You have 9 free searches left this month | for more free features.

Condition

Brain and Central Nervous System Tumors (1)

Lung Cancer (1)

Malignant Melanoma (1)

Ovarian Cancer (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

BioNumerik Pharmaceuticals, Inc. (1)

H. Lee Moffitt Cancer Center and Research Institute (1)

National Cancer Institute (NCI) (1)

Collaborator

BioNumerik Pharmaceuticals, Inc. (1)

Crown Bioscience (1)

National Cancer Institute (NCI) (1)

Intervention

karenitecin (4)

topotecan (1)

valproic acid (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (2)

Industry (1)

NIH (1)

Study Type

Interventional (4)

karenitecin

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ovarian Cancer Trial in Worldwide (Karenitecin, Topotecan)

Completed

Ovarian Cancer

Karenitecin
Topotecan

Budapest, Hungary
+47 more

Mar 10, 2020

Lung Cancer Trial in United States (karenitecin)

Completed

Lung Cancer

karenitecin

La Jolla, California
+43 more

Jul 15, 2016

Malignant Melanoma Trial in Tampa (Karenitecin, Valproic Acid)

Terminated

Malignant Melanoma

Karenitecin
Valproic Acid

Tampa, Florida

H. Lee Moffitt Cancer Center & Research Institute

Nov 21, 2013

Brain and CNS Tumors Trial in United States (karenitecin)

Completed

Brain and Central Nervous System Tumors

karenitecin

Birmingham, Alabama
+7 more

Jul 23, 2008